SCHEMBL8405342

SCHEMBL8405342

OB(O)c1cc2ccc(Br)cc2o1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
HSD17B10 Q99714 2/20 0.58
MGLL Q99685 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
MAOB P27338 2/20 0.40
APP P05067 1/20 0.38
MIF P14174 1/20 0.37
PIM1 P11309 2/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 1/20 0.35
TSHR P16473 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
CYP2A6 P11509 2/20 0.34
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GPR35 Q9HC97 1/20 0.33
MAOA P21397 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL155365 0.85 KDM4E (0.58) KDM4EHSD17B10MGLLTDP1PIM1
SCHEMBL31416604 0.85 KDM4E (0.58) KDM4EHSD17B10MGLLTDP1PIM1
SCHEMBL18305548 0.77 KDM4E (0.58) KDM4EHSD17B10MGLLTDP1MAOB
SCHEMBL19282095 0.74 MAOB (0.42) KDM4EMAOBAPPMIFPIM1
SCHEMBL147973 0.74 KDM4E (1.00) KDM4EHSD17B10MGLLTDP1MAOB
SCHEMBL4494679 0.73 KDM4E (0.53) KDM4EHSD17B10MGLLTDP1MAOB
SCHEMBL12100426 0.73 MGLL (0.53) KDM4EHSD17B10MGLLTDP1MAOB
SCHEMBL30417822 0.73 KDM4E (0.53) KDM4EHSD17B10MGLLTDP1MIF
Naphthalene SCHEMBL29205373 0.72 KDM4E (0.96) KDM4EHSD17B10MGLLTDP1MAOB
SCHEMBL21983882 0.71 MAOB (0.41) KDM4EHSD17B10MAOBAPPMIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114174306-B Organic light-emitting compound and organic light-emitting device SFC株式会社 2024-03-26 CN disclosed
CN-108929234-B Aromatic amine derivative and organic electroluminescent device thereof 长春海谱润斯科技股份有限公司 2021-12-14 CN disclosed
US-20120129828-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC. 2012-05-24 US disclosed
US-20120129828-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC. 2012-05-24 US disclosed
WO-2009154780-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC. (US) 2009-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129828-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF S1PR1, S1PR5, S1PR2 KDM4E 2854/4885HSD17B10 2249/4885MGLL 938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.